Chronic subthalamic stimulation in the treatment of Parkinson's disease. Analysis of results by symptom class and adverse effects;Stimolazione cronica subtalamica per il trattamento della malattia di parkinson: Analisi dei risultati per classe di sintomi ed effetti avversi

Journal of Neurosurgical Sciences

Volumn 47, Issue 1 SUPPL. 1, 2003, Pages 24-27

  Landi, A ^a,c   Antonini, A ^b   Parolin, M ^a   Grimaldi, M ^a   Bassi, F ^a   Iurlaro , S ^a   Gaini, S M ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILANO BICOCCA   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

ADULT; AGED; BRAIN DEPTH STIMULATION; CONFERENCE PAPER; ELECTROSTIMULATION; GLOBUS PALLIDUS; HUMAN; MAJOR CLINICAL STUDY; PARKINSON DISEASE; PREOPERATIVE EVALUATION; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

ADULT; AGED; ELECTRIC STIMULATION THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SUBTHALAMUS;

EID: 0041425159     PISSN: 00264881     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Benabid AL, Krack PP, Benazzouz A, Limousin P, Koudsie A, Pollak P. Deep brain stimulation of the subthalamic nucleus for Parkinson's disease: methodologic aspects and clinical criteria. Neurology 2000;55(12Suppl6):S40-4.
2. Benabid AI, Pollak P, Gross C, Hoffmann D, Benzzouz A, Gao DM et al. Acute and long-term effects of subthalamic nucleus in Parkinson's disease. Stereotact Funct Neurosurg 1994;62:76-84.
3. Krack P, Pollak P, Limousin P, Hoffmann D, Xie J, Benazzouz A et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121:451-7.
4. Limousin P, Pollak P, Benazzouz A, Hoffmann D, Bas JL, Broussolle E et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-5.
5. Ostergaard K, Sunde N, Dupont E. Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations. Mov Disord 2002;17;693-700.
6. Rodriguez-Oroz MC, Gorospe A, Guridi J, Ramos E, Linazasoro G, Rodriguez-Palmero M et al. Bilateral deep brain stimulation of the subthalamic nucleus in Parkinson's disease. Neurology 2000;55(12 Suppl 6):S45-51.
7. Vesper J, Klostermann F, Stockhammer F, Funk T, Brock M. Results of chronic subthalamic nucleus stimulation for parkinson's disease: a 1-year follow-up study. Surg Neurol 2002;57:306-11; discussion 311-3.
8. Moro E, Scerrati M, Romito LMA, Roselli R, Tonali P, Albanese A. Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology 1999;53:85-9.
9. Just H, Ostergaard K. Health-related quality of life in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nuclei. Mov Disord 2002;17:539-45.
10. Martinez-Martin P, Valldeoriola F, Tolosa E, Pilleri M, Molinuevo JL, Rumia J et al. Bilateral subthalamic nucleus stimulation and quality of life in advanced Parkinson's disease. Mov Disord 2002;17:372-7.
11. Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V et al. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus. J Neurol 2002;249:759-66.
12. Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of parkinson's disease: a cost-effectiveness analysis. Neurology 2001;57:663-71.
13. Hariz MI. Complications of deep brain stimulation surgery. Mov Disord 2002;17(Suppl 3):S162-6.
14. Diederich NJ, Alesch F, Goetz CG. Visual hallucinations induced by deep brain stimulation in Parkinson's disease. Clin Neuro-pharmacol 2000;23:287-9.